Deng, Manman <br/><br/>
CS2164 exerts an antitumor effect against human Non-Hodgkin's lymphomas in vitro and in vivo.  [electronic resource] 

 -  Experimental cell research  08 2018 
 - 356-362 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1090-2422 
<br/><br/><label>Standard No.: </label>10.1016/j.yexcr.2018.05.038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Aurora Kinase B--antagonists & inhibitors<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>MAP Kinase Signaling System--drug effects<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Naphthalenes<br/>Phenylenediamines--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Quinolines--pharmacology<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Tumor Stem Cell Assay<br/>Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays